Pasithea Therapeutics Corp. - Common Stock (KTTA)

Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.

The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Wondering what's happening in Thursday's pre-market session? Find an overview in this article.

After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

Pasithea Therapeutics reports encouraging early Phase 1 data for PAS-004, showing no adverse events or toxicities. The trial highlights safety, tolerability, and preliminary efficacy in patients with advanced solid tumors.

Pasithea Therapeutics just reported results for the second quarter of 2024.

Pasithea Therapeutics just reported results for the fourth quarter of 2023.

Pasithea Therapeutics just reported results for the first quarter of 2024.

Pre-market stock movers are worth checking out on Friday as we get into all of the biggest news affecting shares this morning!

Roblox stock is rising higher on Wednesday after Wells Fargo initiated coverage of RBLX shares wit a bullish rating and price target.

Palantir Technologies stock is slipping on Wednesday even with positive news for PLTR investors in the form of a renewed contract.

ReShape Lifesciences stock is rising with heavy trading of RSLS shares alongside an update from the FDA concerning its weight loss products.